Cristiano Trindade

Prof. Cristiano Trindade

Facultad de Ciencias Básicas y Biomédicas, Universidad Simón Bolívar, Barranquilla, Colombia
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JVJosé Vargas
José Vargas
RPRenato Puga
Renato Puga
GLGuido Lenz
Guido Lenz
CTCristiano Trindade
Cristiano Trindade
EFEduardo Filippi-Chiela
Eduardo Filippi-Chiela
Doxorubicin (Doxo) is the most effective chemotherapeutic agent for the treatment of breast cancer. However, resistance to Doxo is common. Adjuvant compounds capable of modulating mechanisms involved in Doxo resistance may potentiate the effectiveness of the drug. Resveratrol (Rsv) has been tested as an adjuvant in mammary malignancies. However, the cellular and molecular mechanisms underlying the effects of cotreatment with Doxo and Rsv in breast cancer are poorly understood. Here, we combined in vitro and in silico analysis to characterize these mechanisms. In vitro, we employed a clinically relevant experimental design consisting of acute (24 h) treatment followed by 15 days of analysis. Acute Rsv potentiated the long-lasting effect of Doxo through the induction of apoptosis and senescence. Cells that survived to the cotreatment triggered high levels of autophagy. Autophagy inhibition during its peak of activation but not concomitant with Doxo+Rsv increased the long-term toxicity of the cotreatment. To uncover key proteins potentially associated with in vitro effects, an in silico multistep strategy was implemented. Chemical-protein networks were predicted based on constitutive gene expression of MCF7 cells and interatomic data from breast cancer. Topological analysis, KM survival analysis, and a quantitative model based on the connectivity between apoptosis, senescence, and autophagy were performed. We found seven putative genes predicted to be modulated by Rsv in the context of Doxo treatment: CCND1, CDH1, ESR1, HSP90AA1, MAPK3, PTPN11, and RPS6KB1. Six out of these seven genes have been experimentally proven to be modulated by Rsv in cancer cells, with 4 of the 6 genes in MCF7 cells. In conclusion, acute Rsv potentiated the long-term toxicity of Doxo in breast cancer potentially through the modulation of genes and mechanisms involved in Doxo resistance. Rational autophagy inhibition potentiated the effects of Rsv+Doxo, a strategy that should be further tested in animal models.

1 April 2019 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
GLGrethel León-Mejía
Grethel León-Mejía
ILIbeth Luna-Rodríguez
Ibeth Luna-Rodríguez
CTCristiano Trindade
Cristiano Trindade
LOLudis Oliveros-Ortíz
Ludis Oliveros-Ortíz
MAMarco Anaya-Romero
Marco Anaya-Romero
MQM. Quintana-Sosa
M. Quintana-Sosa

1 March 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
VJVictoria Jaramillo-García
Victoria Jaramillo-García
CTCristiano Trindade
Cristiano Trindade
ELElisiane Lima
Elisiane Lima
TGTemenouga Guecheva
Temenouga Guecheva
IVIzabel Villela
Izabel Villela
JHJoão Antonio Pegas Henriques
João Antonio Pegas Henriques

22 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Adriana Castro PinheiroAdriana Castro Pinheiro
Adriana Castro Pinheiro
INIanka Jacondino Nunes
Ianka Jacondino Nunes
WFWesley Vieira Ferreira
Wesley Vieira Ferreira
Paula TomasiniPaula Tomasini
Paula Tomasini
CTCristiano Trindade
Cristiano Trindade
JSJenifer Saffi
Jenifer Saffi
Cu(II) complexes bearing NNO-donor Schiff base ligands (2a, b) have been synthesized and characterized. The single crystal X-ray analysis of the 2a complex revealed that a mononuclear and a dinuclear complex co-crystallize in the solid state. The electronic structures of the complexes are optimized by Density Functional Theory (DFT) calculations. The monomeric nature of 2a and 2b species is maintained in solution. Antioxidant activities of the ligands (1a, b) and Cu(II) complexes (2a, b) were determined by in vitro assays such as 1,1-diphenyl-2-picrylhydrazyl free radicals (DPPH.) and 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) radicals (ABTS+). Our results demonstrated that 2a showed better antioxidant activity. MTT assays were performed to assess the toxicity of ligands and Cu(II) complexes in V79 cells. The antiproliferative activity of compounds was tested against two human tumor cell lines: MCF-7 (breast adenocarcinoma) and SW620 (colorectal carcinoma) and on MRC-5 (normal lung fibroblast). All compounds showed high cytotoxicity in the all-cell lines but showed no selectivity for tumor cell lines. Antiproliferative activity by clonogenic assay 2b showed a more significant inhibitory effect on the MCF-7 cell lines than on MRC-5. DNA damage for the 2b compound at 10 µM concentration was about three times higher in MCF-7 cells than in MRC-5 cells.

1 March 2014 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
TGTatiana Siqueira Gonçalves
Tatiana Siqueira Gonçalves
LMLuciane M Menezes
Luciane M Menezes
CTCristiano Trindade
Cristiano Trindade
MMMiriana da Silva Machado
Miriana da Silva Machado
PTPhilip Thomas
Philip Thomas
JHJoão Antonio Pegas Henriques
João Antonio Pegas Henriques

1 October 2011 in Neurobiology of Disease
Verified
Journal Article
Closed access
SGSamuel Greggio
Samuel Greggio
SPSimone de Paula
Simone de Paula
IOIuri M. de Oliveira
Iuri M. de Oliveira
CTCristiano Trindade
Cristiano Trindade
RRRenato M. Rosa
Renato M. Rosa
JDJaderson Costa DaCosta
Jaderson Costa DaCosta